Literature DB >> 22935240

Anterior resection syndrome.

Catherine L C Bryant1, Peter J Lunniss, Charles H Knowles, Mohamed A Thaha, Christopher L H Chan.   

Abstract

Up to 80% of patients with rectal cancer undergo sphincter-preserving surgery. It is widely accepted that up to 90% of such patients will subsequently have a change in bowel habit, ranging from increased bowel frequency to faecal incontinence or evacuatory dysfunction. This wide spectrum of symptoms after resection and reconstruction of the rectum has been termed anterior resection syndrome. Currently, no precise definition or causal mechanisms have been established. This disordered bowel function has a substantial negative effect on quality of life. Previous reviews have mainly focused on different colonic reconstructive configurations and their comparative effects on daily function and quality of life. The present Review explores the potential mechanisms underlying disturbed functions, as well as current, novel, and future treatment options.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22935240     DOI: 10.1016/S1470-2045(12)70236-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  111 in total

1.  Usefulness of Anorectal Manometry for Diagnosing Continence Problems After a Low Anterior Resection.

Authors:  Audrius Dulskas; Narimantas E Samalavicius
Journal:  Ann Coloproctol       Date:  2016-06-30

Review 2.  Treatment possibilities for low anterior resection syndrome: a review of the literature.

Authors:  Audrius Dulskas; Edgaras Smolskas; Inga Kildusiene; Narimantas E Samalavicius
Journal:  Int J Colorectal Dis       Date:  2018-01-08       Impact factor: 2.571

3.  Nerve supply to the internal anal sphincter differs from that to the distal rectum: an immunohistochemical study of cadavers.

Authors:  Yusuke Kinugasa; Takashi Arakawa; Gen Murakami; Mineko Fujimiya; Kenichi Sugihara
Journal:  Int J Colorectal Dis       Date:  2013-12-05       Impact factor: 2.571

4.  National German Guideline (S2k): Guideline for the Diagnosis and Treatment of Endometriosis: Long Version - AWMF Registry No. 015-045.

Authors:  U Ulrich; O Buchweitz; R Greb; J Keckstein; I von Leffern; P Oppelt; S P Renner; M Sillem; W Stummvoll; R-L De Wilde; K-W Schweppe
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-12       Impact factor: 2.915

Review 5.  Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review.

Authors:  Marco E Allaix; Alberto Arezzo; Mario Morino
Journal:  Surg Endosc       Date:  2016-02-22       Impact factor: 4.584

6.  Quality of life in non-early rectal cancer treated by neoadjuvant radio-chemotherapy and endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM) versus laparoscopic total mesorectal excision.

Authors:  Giancarlo D'Ambrosio; Alessandro M Paganini; Andrea Balla; Silvia Quaresima; Pietro Ursi; Paolo Bruzzone; Andrea Picchetto; Fabrizio I Mattei; Emanuele Lezoche
Journal:  Surg Endosc       Date:  2015-06-05       Impact factor: 4.584

Review 7.  [Evidence-based surgery of rectal cancer].

Authors:  M Grade; H Flebbe; B M Ghadimi
Journal:  Chirurg       Date:  2019-05       Impact factor: 0.955

8.  Long-term functional follow-up after anterior rectal resection for cancer.

Authors:  Alessandro Sturiale; Jacopo Martellucci; Letizia Zurli; Carla Vaccaro; Luigi Brusciano; Paolo Limongelli; Ludovico Docimo; Andrea Valeri
Journal:  Int J Colorectal Dis       Date:  2016-09-30       Impact factor: 2.571

9.  Outcome of bowel function following anterior resection for rectal cancer-an analysis using the low anterior resection syndrome (LARS) score.

Authors:  Juliane Kupsch; Thomas Jackisch; Klaus E Matzel; Joerg Zimmer; Andreas Schreiber; Anja Sims; Helmut Witzigmann; Sigmar Stelzner
Journal:  Int J Colorectal Dis       Date:  2018-03-15       Impact factor: 2.571

10.  Effect of Neoadjuvant Systemic Chemotherapy With or Without Chemoradiation on Bowel Function in Rectal Cancer Patients Treated With Total Mesorectal Excision.

Authors:  Felipe Quezada-Diaz; Rosa M Jimenez-Rodriguez; Emmanouil P Pappou; J Joshua Smith; Sujata Patil; Iris Wei; Jose G Guillem; Philip B Paty; Garrett M Nash; Martin R Weiser; Julio Garcia-Aguilar
Journal:  J Gastrointest Surg       Date:  2018-10-22       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.